YOLFTbeta
00

Anhui Fengyuan Pharmaceutical Co Ltd

000153 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

5.31CNY-0.03 (-0.56%)

Price History

Full chart

Market Stats

Previous Close5.34
Open5.35
Day Range5.28 – 5.41
52-Week Range4.95 – 7.35
Volume8.40M
Market Cap2.84B
P/E (TTM)30.55
Forward P/E47.62
EPS0.20
Dividend Yield1.64%
Beta0.37
50-Day Avg5.99
200-Day Avg6.16

About

Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company also exports its products. Anhui Fengyuan Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Hefei, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Tianle Ru
  • Employees4.28K
  • HeadquartersNo.16 Dalian Road, Hefei, China, China
  • Websitehttps://www.bbcayy.com

Leadership

  • Mr. Tianle RuGM & Director · b. 1985
  • Mr. Jun LiChief Financial Officer · b. 1977
  • Ms. Xiaojing ChenDeputy General Manager · b. 1977
  • Mr. Jinchao DuanDeputy GM & Employee Representative Director · b. 1983
  • Mr. Jun ZhangSecretary of the Board · b. 1970
  • Mr. Guo Kun LiDeputy General Manager · b. 1972
  • Mr. Shuang Qing YinDeputy General Manager · b. 1969
  • Mr. Zheng WuDeputy General Manager · b. 1981
  • Zhirui ChenHead of Accounting Department & Accounting Supervisor
  • Mr. De Hao LuDeputy General Manager · b. 1980

Financials

Income Statement

Currency: CNY1997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue44.11M49.63M57.21M114.15M159.21M157.94M179.12M280.54M441.21M521.29M703.78M873.81M955.70M1.07B1.52B1.66B1.53B1.70B1.57B2.03B2.58B3.01B3.24B3.32B3.65B4.00B4.28B4.28B3.86B
Growth (%)-+12.51%+15.26%+99.53%+39.48%-0.80%+13.41%+56.62%+57.27%+18.15%+35.01%+24.16%+9.37%+12.40%+41.18%+9.32%-7.71%+11.05%-7.62%+29.58%+26.77%+16.88%+7.46%+2.57%+9.97%+9.63%+6.78%+0.21%-9.95%
Cost of Revenue28.21M31.49M35.61M69.49M80.66M85.99M110.20M205.68M328.78M392.28M527.86M640.25M693.49M788.84M1.21B1.28B1.13B1.25B1.15B1.50B1.79B1.85B2.01B2.18B2.57B2.88B3.18B3.36B3.15B
Gross Profit15.91M18.14M21.60M44.65M78.55M71.95M68.93M74.86M112.43M129.01M175.92M233.55M262.20M285.34M303.31M380.51M397.55M448.80M422.65M534.61M784.10M1.17B1.23B1.15B1.08B1.12B1.09B927.30M708.89M
Gross Margin36.05%36.56%37.76%39.12%49.34%45.56%38.48%26.69%25.48%24.75%25.00%26.73%27.44%26.56%20.00%22.95%25.99%26.42%26.93%26.29%30.41%38.72%38.01%34.50%29.59%27.95%25.51%21.64%18.37%
Operating Expense10.41M10.39M13.01M15.12M47.96M40.25M44.82M58.33M101.26M116.59M160.89M213.70M235.28M245.73M295.42M347.37M350.91M402.89M388.63M543.87M687.97M1.07B1.11B1.02B923.88M899.88M877.56M722.21M522.69M
Operating Income5.49M7.75M8.59M29.53M30.59M31.70M24.11M16.53M11.17M12.43M15.03M19.86M26.92M39.61M7.89M33.14M46.64M45.91M34.02M-9.26M96.14M92.55M124.11M130.55M156.68M219.30M213.25M205.09M186.20M
Operating Margin12.46%15.62%15.02%25.87%19.21%20.07%13.46%5.89%2.53%2.38%2.14%2.27%2.82%3.69%0.52%2.00%3.05%2.70%2.17%-0.46%3.73%3.07%3.83%3.93%4.29%5.48%4.99%4.79%4.83%
EBITDA7.91M10.04M15.13M34.52M44.73M51.09M53.35M50.49M58.56M87.88M71.36M80.23M96.03M117.75M82.00M98.29M122.09M157.71M142.53M165.10M205.13M198.93M227.58M248.43M287.44M331.58M350.42M340.35M308.75M
EBITDA Margin17.94%20.22%26.44%30.24%28.10%32.35%29.78%18.00%13.27%16.86%10.14%9.18%10.05%10.96%5.41%5.93%7.98%9.28%9.08%8.12%7.96%6.60%7.03%7.48%7.87%8.28%8.20%7.94%8.00%
Net Income4.47M7.69M8.64M26.27M24.77M25.82M18.12M9.59M9.03M22.00M5.63M14.18M22.99M41.63M9.91M19.02M27.35M40.99M35.18M45.84M65.35M60.93M80.92M103.72M122.98M154.43M159.29M160.83M99.42M
Net Income Margin10.13%15.50%15.09%23.01%15.56%16.35%10.12%3.42%2.05%4.22%0.80%1.62%2.41%3.88%0.65%1.15%1.79%2.41%2.24%2.25%2.53%2.02%2.50%3.12%3.37%3.86%3.73%3.75%2.58%
R&D-------------25.14M22.86M20.70M24.33M26.70M30.96M29.69M59.67M72.88M77.96M75.47M76.02M65.47M77.02M71.03M48.94M
R&D as % of Total Revenue-------------2.34%1.51%1.25%1.59%1.57%1.97%1.46%2.31%2.42%2.41%2.27%2.08%1.64%1.80%1.66%1.27%
Interest Expense2.15M1.75M2.10M2.51M3.68M2.22M3.32M6.50M14.56M19.64M16.24M18.42M17.67M14.50M16.26M20.59M22.10M32.56M32.50M29.76M33.63M35.61M42.05M43.87M42.00M35.74M34.64M31.25M35.20M
Interest Expense % of Total Revenue4.87%3.53%3.67%2.20%2.31%1.40%1.85%2.32%3.30%3.77%2.31%2.11%1.85%1.35%1.07%1.24%1.44%1.92%2.07%1.46%1.30%1.18%1.30%1.32%1.15%0.89%0.81%0.73%0.91%

Balance Sheet

Currency: CNY1997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets58.92M110.33M134.63M634.79M709.48M684.42M736.92M895.92M1.09B1.07B1.09B1.17B1.21B1.28B1.32B1.45B1.98B2.24B2.31B2.49B2.77B3.01B3.56B3.64B3.82B4.47B4.39B4.70B5.06B
Total Liabilities34.89M65.98M81.65M102.28M173.33M123.55M160.93M304.86M493.08M445.10M449.73M511.47M526.78M522.02M552.99M675.47M926.72M1.09B1.12B1.34B1.55B1.72B2.23B2.19B2.26B2.71B2.47B2.65B2.93B
Total Equity24.03M43.27M51.90M531.42M535.07M560.87M576.00M585.59M594.61M615.38M633.42M647.60M671.49M713.54M723.45M734.16M1.01B1.11B1.15B1.15B1.22B1.29B1.32B1.41B1.53B1.73B1.89B2.02B2.10B
Cash3.30M1.67M4.37M381.19M208.14M95.02M59.05M128.22M159.94M81.40M59.50M109.68M107.26M96.42M57.43M65.74M308.93M167.89M164.88M156.49M262.40M303.59M350.73M275.34M251.30M353.14M319.91M250.82M386.96M
Total Debt20.55M30.38M37.58M48.98M69.98M43.50M75.00M171.50M308.00M253.68M174.80M218.50M281.40M271.40M258.20M339.50M472.54M531.03M552.40M573.00M509.80M367.18M597.88M609.62M615.12M787.96M687.76M692.78M-
Net Debt17.25M28.71M33.21M-332.21M-138.16M-51.52M15.95M43.28M148.06M172.28M115.30M108.82M174.14M174.98M200.77M273.76M163.61M363.14M387.52M416.51M247.39M63.59M247.15M334.29M363.81M434.82M219.35M441.95M458.63M

Cash Flow

Currency: CNY1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.01M25.88M23.57M10.48M-11.46M-11.72M34.88M36.27M55.26M49.82M32.41M55.04M55.06M45.65M-70.31M10.51M45.50M78.21M52.40M233.59M66.21M292.75M237.88M439.99M254.75M126.24M119.30M
Investing Cash Flow-4.59M-117.82M-215.23M-93.18M-54.48M-11.49M-124.50M-43.38M30.47M-24.83M-80.05M-42.51M-66.16M-98.47M-50.07M-164.88M-43.38M-57.80M-34.73M-161.98M-363.02M-84.91M-149.73M-99.39M-143.66M-251.45M-
Financing Cash Flow6.29M468.76M18.60M-30.41M29.97M92.38M121.34M-71.43M-107.52M25.28M45.23M-23.37M-27.87M60.43M363.41M13.36M-9.47M-47.82M48.05M-11.89M287.10M-209.82M-106.02M-262.27M-165.20M50.63M-
Capital Expenditure4.59M117.82M190.24M91.40M56.64M46.98M35.68M136.67M35.18M31.58M74.42M89.75M69.86M95.06M113.90M175.86M50.33M22.17M47.99M84.63M145.62M190.74M157.36M81.76M152.12M144.02M220.61M
Free Cash Flow-3.57M-91.94M-166.67M-80.93M-68.10M-58.70M-798.97K-100.40M20.08M18.24M-42.01M-34.71M-14.80M-49.41M-184.21M-165.35M-4.83M56.05M4.41M148.96M-79.40M102.01M80.52M358.23M102.64M-17.78M-101.31M
Dividends Paid2.91M2.63M7.43M16.93M4.70M6.50M15.16M17.11M16.24M18.42M17.67M14.87M16.17M20.87M50.77M32.02M30.83M60.42M34.40M31.67M51.70M38.40M26.28M31.21M64.17M72.17M81.16M
FCF to OCF-352.80%-355.29%-707.19%-772.53%594.32%500.98%-2.29%-276.83%36.34%36.61%-129.65%-63.07%-26.87%-108.23%262.00%-1573.15%-10.61%71.66%8.41%63.77%-119.92%34.84%33.85%81.42%40.29%-14.09%-84.92%
Dividend Paid to FCF-81.52%-2.86%-4.45%-20.92%-6.91%-11.08%-1897.71%-17.04%80.87%100.98%-42.07%-42.83%-109.32%-42.24%-27.56%-19.36%-638.51%107.81%780.26%21.26%-65.11%37.65%32.64%8.71%62.53%-405.89%-80.12%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 25, 2016Sep 30, 2016Dec 31, 2016Apr 26, 2017Aug 24, 2017Oct 25, 2017Dec 31, 2017Apr 27, 2018Aug 29, 2018Oct 30, 2018Dec 31, 2018Apr 25, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 24, 2020Aug 28, 2020Oct 29, 2020Dec 31, 2020Apr 23, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Feb 22, 2024May 22, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 22, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------------------
EPS Actual0.010.050.040.020.010.020.01-0.010.010.020.020.010.010.020.020.010.010.030.040.010.010.030.030.000.010.060.040.010.030.110.050.010.040.090.060.010.050.090.040.010.070.120.040.080.090.080.060.060.080.120.080.040.100.120.080.050.140.110.100.030.080.080.05-0.000.080.07
Surprise------------------------------------------------------------------
Timing-------------------------After-hours--After-hoursAfter-hoursPre-market-Pre-marketPre-marketPre-market-After-hours------------------After-hoursAfter-hours---After-hours-----

Key Statistics & Ratios

Market Cap2.84B
Enterprise Value3.90B
Trailing P/E30.55
Forward P/E47.62
PEG Ratio0.00
Price / Sales0.81
Price / Book1.33
EPS0.20
Book Value4.66
Revenue (TTM)3.50B
Gross Profit (TTM)662.71M
EBITDA217.46M
Profit Margin2.70%
Operating Margin2.31%
Return on Equity4.19%
Return on Assets1.22%
Shares Outstanding464.69M
Shares Float334.14M
Beta0.37
Dividend Yield1.64%
Dividend Rate0.10
Payout Ratio49.21%

Dividends

20261×
0.10Jun 18, 2026
20251×
0.10May 30, 2025
20241×
0.11Jun 7, 2024
20231×
0.07Jun 16, 2023
20221×
0.07Jul 5, 2022
20191×
0.07Jul 24, 2019
20161×
0.07Aug 11, 2016
20131×
0.07May 30, 2013
20031×
0.01Oct 31, 2003
20011×
0.03Oct 23, 2001

Stock Splits

  • Jun 7, 20241.4:1
  • Jun 21, 20052:1
  • Oct 31, 200320:10